Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

DOH-FLY

From Wikipedia, the free encyclopedia
Not to be confused withFLY (psychedelics).

Pharmaceutical compound
DOH-FLY
Clinical data
Other namesFLY; H-FLY; HFLY
Drug classSerotonin receptor agonist;Serotonin5-HT2A receptoragonist
ATC code
  • None
Identifiers
  • 1-(2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-4-yl)propan-2-amine
CAS Number
PubChemCID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC13H17NO2
Molar mass219.284 g·mol−1
3D model (JSmol)
  • CC(CC1=C2C(=CC3=C1CCO3)CCO2)N
  • InChI=1S/C13H17NO2/c1-8(14)6-11-10-3-5-15-12(10)7-9-2-4-16-13(9)11/h7-8H,2-6,14H2,1H3
  • Key:QTMQYHDNFFQCRI-UHFFFAOYSA-N

DOH-FLY, also known simply asFLY orH-FLY, is aserotonin receptor agonist of thephenethylamine,DOx, andFLY families.[1][2][3][4] It is the "FLY" (benzodidihydrofuran)analogue of2,5-dimethoxyamphetamine (2,5-DMA or DOH).[1][4]

Pharmacology

[edit]

Theenantiomers of FLY, (R)-FLY and (S)-FLY, showaffinity and activity at theserotonin5-HT2 receptors.[1][4] At the serotonin5-HT2A receptor, the affinity (Ki) of (R)-FLY was 54.4 nM and of (S)-FLY was 227 nM, while at the serotonin5-HT2C receptor, the affinity (Ki) of (R)-FLY was 8.2 nM and of (S)-FLY was 119 nM.[4] In terms ofactivationalpotency at the serotonin 5-HT2A receptor, theEC50Tooltip half-maximal effective concentration (EmaxTooltip maximal efficacy) of (R)-FLY was 5,650 nM (99%) while that of (S)-FLY was 2,360 nM (62%).[4] The enantiomers of FLY have greater activity as serotonin 5-HT2A receptor agonists than (R)-2,5-DMA but show dramatically lower potency than 4-substituted FLY analogues likeDOB-FLY.[4] In other studies, the affinity (Ki) ofracemic FLY for the serotonin 5-HT2A receptor was 2,010 nM, relative to 15 to 18 nM for DOB-FLY, 0.23 nM forBromo-DragonFLY, and 5,200 nM for 2,5-DMA.[3][5]

FLY was included and described as an entry inAlexander Shulgin's 2011 bookThe Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds.[1] It partially substituted forLSD in rodentdrug discrimination tests, with a maximal substitution of 64% at a dose of 4.0 mmol/kg.[3] The drug was markedly less potent in these tests than 4-substituted analogues like DOB-FLY.[3] Thepharmacokinetics of FLY in rats have been studied.[6] FLY is not known to have been assessed in humans, and hence it is unknown whether FLY haspsychedelic or otherpsychoactive effects in humans.[1]

History

[edit]

FLY was first described in thescientific literature by 1995.[1][3][7] It was not an explicitlycontrolled substance in theUnited States as of 2011.[1]

See also

[edit]

References

[edit]
  1. ^abcdefgShulgin A, Manning T, Daley PF (2011)."#68. FLY".The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. pp. 141–143.ISBN 978-0-9630096-3-0.OCLC 709667010.
  2. ^Trachsel D, Lehmann D, Enzensperger C (2013).Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1st ed.). Solothurn: Nachtschatten-Verlag. pp. 497–499, 515,928–929.ISBN 978-3-03788-700-4.OCLC 858805226.
  3. ^abcdeMonte AP, Marona-Lewicka D, Parker MA, Wainscott DB, Nelson DL, Nichols DE (July 1996)."Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups".Journal of Medicinal Chemistry.39 (15):2953–2961.doi:10.1021/jm960199j.PMID 8709129.
  4. ^abcdefChambers JJ, Kurrasch-Orbaugh DM, Parker MA, Nichols DE (March 2001). "Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists".Journal of Medicinal Chemistry.44 (6):1003–1010.doi:10.1021/jm000491y.PMID 11300881.
  5. ^Parker MA, Kurrasch DM, Nichols DE (April 2008)."The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands".Bioorganic & Medicinal Chemistry.16 (8):4661–4669.doi:10.1016/j.bmc.2008.02.033.PMC 2442558.PMID 18296055.
  6. ^Baralla E, Nieddu M, Burrai L, Varoni MV, Demontis MP, Boatto G (May 2019). "LC-MS/MS analysis of two new designer drugs (FLY serie) in rat plasma and its application to a pharmacokinetic study".Legal Medicine.38. Tokyo, Japan:58–63.doi:10.1016/j.legalmed.2019.04.004.PMID 30991226.
  7. ^Monte AP (1995)."Structure-activity relationships of hallucinogens: Design, synthesis, and pharmacological evaluation of a series of conformationally restricted phenethylamines".Purdue e-Pubs. Archived from the original on 15 September 2024. Retrieved17 June 2025.{{cite web}}: CS1 maint: bot: original URL status unknown (link)

External links

[edit]


Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=DOH-FLY&oldid=1322753464"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp